TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Tech Stocks
Checklist: 4 Variables to Help us Find a Winning Stock
Investing
3 Marijuana Stocks to Buy Today

Dividend Stocks
4 Things to Remember in Turbulent Times

Investing
Strong Revenue Growth for Canopy Growth Corp., but the Best Is Yet to Come
Investing
It’s Time for Cannabis Investors to Face the Elephant in the Room

Investing
Canopy Growth Corp. Shows the Market How Fast a Weed Should Grow

Investing
What Do U.S. Cannabis Sales Reveal About the Canadian Legal Cannabis Market?
Investing
Why You Shouldn’t Get Too Excited by Canopy Growth Corp.’s Q3 Results
Tech Stocks
Marijuana Investors: Will Shopify Inc. Be the Go-To Platform for Online Cannabis Sales?

Investing
Canopy Growth Corp.: What to Look Forward to as the Marijuana Giant Reports Quarterly Results on Wednesday

Investing
Marijuana Stocks: Is Canopy Growth Corp. Stock a Buy Under $30?
